Steven Greenberg
Steven Greenberg
assess begun class completing device evaluate exciting failure forward fully heart iii innovative meet moderate needs order patients potential safety severe study technology treat
The Optimizer is an exciting and innovative technology with the potential to treat patients with Class III or Class IV heart failure. We have already begun enrolling patients in the FIX-HF-5 study to evaluate the safety and effectiveness of the Optimizer. We look forward to completing new patient enrollment in order to fully assess the potential of this device to meet the needs of moderate to severe heart failure patients.